BioSpace News Archive

Deals

Pfizer Acquires Amplyx Pharmaceuticals

Deal expands anti-infectives pipeline with addition of novel antifungal Phase 2 candidate, Fosmanogepix (APX001) Opportunity to advance Pfizer’s expertise and deep heritage in infectious disease

April 28, 2021
·
8 min read
BioMidwest

Depression Disconnect: GeneSight® Mental Health Monitor Shows Misunderstanding of Depression and TreatmentNew poll shows 83% of people with depression agree life would be easier if others could understand their depression

In a new nationwide poll, the GeneSight® Mental Health Monitor found that 83% of people with depression agree that life would be easier if others could understand their depression.

April 28, 2021
·
6 min read
Upper Respiratory Tract Infection Treatment Market | Latest Trends and Cardinal Growth Prospects Detailed Analysis Report

A considerable rise in the cases of upper respiratory tract infections due to factors like dense pollution levels and frequent climate changes may bring good growth opportunities for the upper respiratory tract infection treatment market during the forecast period of 2019-2029.

April 28, 2021
·
4 min read
Osteoporosis Drugs Market: North America to Dominate Global Market

Transparency Market Research has published a new report titled, ‘Osteoporosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

April 28, 2021
·
5 min read
Hemophilia Treatment Drugs Market: Favorable Governmental Polices to Drive Market

Some of the prominent players operating in the global hemophilia treatment drugs market are Pfizer, Inc., Kedrion, Shire Plc., CSL Behring, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Bayer AG, and Sanofi, finds Transparncy Market Reseach.

April 28, 2021
·
4 min read
Erectile Dysfunction Drugs Market: Growth Witnessed in Retail Segment to Boost Market

The consequences of lifestyle diseases are aplenty. One condition like obesity, hypertension, or diabetes which are also result of stress, can be dangerous to the entire body.

April 28, 2021
·
4 min read
New Distribution Facility Expands Bushu Pharma’s Gateway to Asia (GTA) Services

Agreement Reached with Suzuken Group Subsidiary Chuo Unyu to Establish Kazo Packaging Center, Further Enabling Premier Japanese CDMO’s Prompt and Reliable Pharmaceutical Contract Manufacturing Services

April 28, 2021
·
2 min read
DIC Invests in Israeli Biotech Startup Vaxa Technologies

DIC Corporation has completed investment in Vaxa Technologies Ltd., a biotech startup headquartered in Rosh Pina, Israel, as part of a strategic expansion of DIC businesses around health food and other algae-derived products.

April 28, 2021
·
2 min read
Business

Medivir AB - Interim Report January - March 2021

In January the company signed an exclusive license agreement with IGM Biosciences, Inc. for birinapant. Medivir received a payment of USD 1 million after signing, which is to be followed by an additional USD 1.5 million when IGM includes birinapant in phase I clinical trials.

April 28, 2021
·
7 min read
Biotech Beach

Amgen Provides Updated Information On LUMAKRAS™ (Sotorasib)¹ Dose Comparison Study

Amgen announced that it agreed last night with the FDA’s proposed post-marketing requirement to conduct, as part of the ongoing development program, a multi-center randomized clinical trial to compare the safety and efficacy of LUMAKRAS™ at 960 mg once daily versus a lower daily dose of the drug.

April 28, 2021
·
7 min read